High plasma concentrations of organic pollutants negatively impact survival in amyotrophic lateral sclerosis.


Journal

Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R

Informations de publication

Date de publication:
08 2019
Historique:
received: 08 10 2018
revised: 28 12 2018
accepted: 18 01 2019
pubmed: 15 2 2019
medline: 24 3 2020
entrez: 15 2 2019
Statut: ppublish

Résumé

To determine whether persistent organic pollutants (POP) affect amyotrophic lateral sclerosis (ALS) survival. ALS participants seen at the University of Michigan (Ann Arbor, MI, USA) provided plasma samples for measurement of POPs. ALS disease and clinical features were collected prospectively from the medical records. Survival models used a composite summary measure of exposure due to multiple POPs (environmental risk score or ERS). 167 participants (40.7% female, n=68) with ALS were recruited, of which 119 died during the study period. Median diagnostic age was 60.9 years (IQR 52.7-68.2), median time from symptom onset to diagnosis was 1.01 years (IQR 0.67-1.67), bulbar onset 28.7%, cervical onset 33.5% and lumbar onset 37.7%. Participants in the highest quartile of ERS (representing highest composite exposure), adjusting for age at diagnosis, sex and other covariates had a 2.07 times greater hazards rate of mortality (p=0.018, 95% CI 1.13 to 3.80) compared with those in the lowest quartile. Pollutants with the largest contribution to the ERS were polybrominated diphenyl ethers 154 (HR 1.53, 95% CI 0.90 to 2.61), polychlorinated biphenyls (PCB) 118 (HR 1.50, 95% CI 0.95 to 2.39), PCB 138 (HR 1.69, 95% CI 0.99 to 2.90), PCB 151 (HR 1.46, 95% CI 1.01 to 2.10), PCB 175 (HR 1.53, 95% CI 0.98 to 2.40) and p,p'-DDE (HR 1.39, 95% CI 1.07 to 1.81). Higher concentrations of POPs in plasma are associated with reduced ALS survival, independent of age, gender, segment of onset and other covariates. This study helps characterise and quantify the combined effects of POPs on ALS and supports the concept that environmental exposures play a role in disease pathogenesis.

Identifiants

pubmed: 30760645
pii: jnnp-2018-319785
doi: 10.1136/jnnp-2018-319785
pmc: PMC6625908
mid: NIHMS1020142
doi:

Substances chimiques

Environmental Pollutants 0
Halogenated Diphenyl Ethers 0
Polychlorinated Biphenyls DFC2HB4I0K

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

907-912

Subventions

Organisme : NIEHS NIH HHS
ID : K23 ES027221
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Neurol Sci. 1999 Oct 31;169(1-2):13-21
pubmed: 10540002
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
Lifetime Data Anal. 2007 Sep;13(3):333-50
pubmed: 17661175
Stat Med. 2009 Jul 10;28(15):1982-98
pubmed: 19452569
Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):310-23
pubmed: 19922118
Springerplus. 2013 May 14;2(1):222
pubmed: 23853744
Environ Health. 2013 Oct 04;12(1):85
pubmed: 24093917
Nat Rev Neurol. 2013 Nov;9(11):617-28
pubmed: 24126629
PLoS One. 2014 Jun 05;9(6):e98632
pubmed: 24901996
PLoS One. 2014 Jun 30;9(6):e101186
pubmed: 24979055
Neurology. 2015 Jan 20;84(3):251-8
pubmed: 25527265
JAMA Neurol. 2015 Jul;72(7):743-4
pubmed: 25961436
Acc Chem Res. 2015 Jul 21;48(7):1853-61
pubmed: 26050713
Epidemiology. 2015 Nov;26(6):821-3
pubmed: 26414852
J Stat Softw. 2011 Mar;39(5):1-13
pubmed: 27065756
JAMA Neurol. 2016 Jul 1;73(7):779-80
pubmed: 27158795
JAMA Neurol. 2016 Jul 1;73(7):803-11
pubmed: 27159543
JAMA Neurol. 2016 Jul 1;73(7):812-20
pubmed: 27244217
Continuum (Minneap Minn). 2017 Oct;23(5, Peripheral Nerve and Motor Neuron Disorders):1332-1359
pubmed: 28968365
Neuron. 2018 Mar 21;97(6):1268-1283.e6
pubmed: 29566793
Ann Neurol. 1997 Feb;41(2):210-21
pubmed: 9029070

Auteurs

Stephen A Goutman (SA)

Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA sgoutman@med.umich.edu.
Program for Neurology Research and Discovery, University of Michigan, Ann Arbor, Michigan, USA.

Jonathan Boss (J)

Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.

Adam Patterson (A)

Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
Program for Neurology Research and Discovery, University of Michigan, Ann Arbor, Michigan, USA.

Bhramar Mukherjee (B)

Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.

Stuart Batterman (S)

Department of Environmental Health Sciences, University of Michigan, Ann Arbor, Michigan, USA.

Eva L Feldman (EL)

Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
Program for Neurology Research and Discovery, University of Michigan, Ann Arbor, Michigan, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH